JP MORGAN/CALL/BOSTON SCIENTIFIC/70/0.1/15.11.24 | Real-time Bid/Ask 10:17:24 2024-07-02 EDT | ||
| 1.01 EUR / 1.02 EUR | -7.73% |
|
| 1 month | +5.77% | ||
| 3 months | +37.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-02 | 1.04 | -5.45% |
| 24-07-01 | 1.1 | 0.00% |
| 24-06-28 | 1.1 | +0.92% |
| 24-06-27 | 1.09 | -6.03% |
| 24-06-26 | 1.16 | +5.45% |
Delayed Quote Börse Stuttgart
Last update July 02, 2024 at 02:43 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK45TX |
| ISIN | DE000JK45TX2 |
| Date issued | 2024-03-19 |
| Strike | 70 $ |
| Maturity | 2024-11-15 (136 Days) |
| Parity | 10 : 1 |
| Emission price | 0.43 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.19 € |
|---|---|
| Lowest since issue | 0.71 € |
| Delta | 0.72x |
| Omega | 4.958 |
| Premium | 6.39x |
| Gearing | 6.92x |
| Moneyness | 1.088 |
| Difference Strike | -6.025 $ |
| Difference Strike % | -8.61% |
| Spread | 0.01 € |
| Spread % | 0.97% |
| Theoretical value | 1.025 |
| Implied Volatility | 37.29 % |
| Total Loss Probability | 36.55 % |
| Intrinsic value | 0.5715 |
| Present value | 0.4535 |
| Break even | 80.99 € |
| Theta | -0.02x |
| Vega | 0.01x |
| Rho | 0.02x |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.41
USD
Average target price
82.35
USD
Spread / Average Target
+7.78%
- Stock Market
- Warrants
- Warrant
